Want to join the conversation?
Janssen-Cilag International, a $JNJ company, received CHMP positive opinion for Stelara (ustekinumab) recommending approval for treatment of moderately to severely active Crohn's disease. Crohn's disease is a chronic inflammatory condition of the gastrointestinal tract that affects nearly 250,000 Europeans.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.